news_image.jpg

Treatment success for diabetic kidney disease

16 Apr 2019



Clinical trial findings in The New England Journal of Medicine report that canagliflozin can reduce the risk of kidney and cardiac failure in patients with diabetes.

iNews



Issue 43 - Spring 2019

Latest Newsletter

Issue 43 - Spring 2019

Issue 43 - Spring 2019

Newsletter Archive

Previous newsletters can be viewed and downloaded from the archive.

Newsletter Archive